🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Eye Tracking to Aid in Autism Risk Detection

RecruitingNAAges 12 Months - 48 MonthsAllIndiana University
NCT06471504 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Young children ages 12-48 months scheduled for health care visits at Riley Hospital for Children at Indiana University Health clinics (e.g., Pediatric Care Center clinics). * Children must have English- or Spanish-speaking caregivers. * Children must have a legal guardian that is able to provide consent. Exclusion Criteria: * Child is younger than 12 months or older than 48 months. * Child's caregiver(s) is not English- or Spanish-speaking.
💊

What it tests

  • Eyelink Portable Duo
📍

Where

1 site
Riley Hospital for Children
Indianapolis, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy